Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Debt Ratio (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Debt Ratio for 15 consecutive years, with 0.35 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt Ratio rose 47.12% year-over-year to 0.35, compared with a TTM value of 0.35 through Sep 2025, up 47.12%, and an annual FY2024 reading of 0.21, down 1.11% over the prior year.
  • Debt Ratio was 0.35 for Q3 2025 at BioRestorative Therapies, up from 0.3 in the prior quarter.
  • Across five years, Debt Ratio topped out at 2.71 in Q3 2021 and bottomed at 0.01 in Q4 2021.
  • Average Debt Ratio over 5 years is 0.42, with a median of 0.3 recorded in 2025.
  • The sharpest move saw Debt Ratio plummeted 98.6% in 2021, then surged 2350.48% in 2022.
  • Year by year, Debt Ratio stood at 0.01 in 2021, then soared by 2350.48% to 0.34 in 2022, then tumbled by 38.44% to 0.21 in 2023, then fell by 1.11% to 0.21 in 2024, then skyrocketed by 69.92% to 0.35 in 2025.
  • Business Quant data shows Debt Ratio for BRTX at 0.35 in Q3 2025, 0.3 in Q2 2025, and 0.31 in Q1 2025.